Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
ReNeuron Group (RENE)
Share Price: 27.00p Change Today: 0.50p  Market Cap: 15.41m

ReNeuron Group Overview

ReNeuron is a UK based Proprietary Stem Cell based Exosome Technologies company. Its primary objective is the development of novel stem cell based technologies targeting areas of significant unmet or poorly met medical need.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

ReNeuron Group Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-18 0.04 (20.97) (54.23)p n/a n/a n/a n/a 0.0%
31-Mar-19 0.05 (17.23) (44.11)p n/a n/a n/a n/a 0.0%
31-Mar-20 6.07 (13.86) (34.96)p n/a n/a n/a n/a 0.0%
31-Mar-21 0.26 (13.41) (29.00)p n/a n/a n/a n/a 0.0%
31-Mar-22 0.40 (11.06) (17.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

ReNeuron Group Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-23 0.69 (11.22) (16.66)p n/a n/a n/a n/a 0.0%
31-Mar-24 0.66 (11.75) (17.38)p n/a n/a n/a n/a 0.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

ReNeuron Group Company Announcements

Posting of AR & Accounts & Notice of AGM 15-Aug-2022 15:25 RNS
Directorate Change 01-Aug-2022 07:00 RNS
Grant of Options 15-Jul-2022 07:00 RNS

Latest ReNeuron Group Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.


Price Data

Currency UK Pounds
Share Price 27.00p
Change Today 0.50p
% Change 1.89 %
Volume 35,333
17-Aug-22 Close 26.50p
Shares Issued 57.06m
Market Cap 15.41m
Year End 31-Mar-22

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ReNeuron Group Dividends

No dividends found

Trades for 18-Aug-2022

Time Volume / Share Price
16:40 5 @ 28.00p
16:35 11,800 @ 27.00p
16:20 18,674 @ 26.62p
12:16 1,773 @ 27.74p
10:51 81 @ 26.62p

ReNeuron Group Key Personnel

CFO Catherine Isted